In the exhilarating yet unpredictable realm of stock investing, chasing stability might feel like a safe harbor, but could it secretly be sabotaging your path to extraordinary wealth? Picture this: you're sailing through calm waters, but while others are catching the big waves of bull markets, you might be left watching from the shore. It's a dilemma that keeps investors up at night—balancing the allure of low-risk plays against the thrill of potentially life-changing returns. But here's where it gets controversial: are low-volatility stocks really the underdogs they seem, or are they just playing it too safe in a world that rewards bold moves? Stick around, because we're about to dive deep into this tension, uncovering one steady stock with promising edges and two that might be battling fierce winds. And this is the part most people miss: understanding these dynamics could be the key to unlocking smarter investment strategies that work for you, no matter the market mood.
Navigating the fine line between security and profitability is no small feat, which is exactly why tools like StockStory exist to guide you through the maze. With that in mind, let's spotlight one low-volatility gem that could deliver reliable growth, alongside two others that might falter under pressure. For beginners, low-volatility stocks are those that don't swing wildly in price—think of them as the dependable family sedan in a world of sports cars. Their beta, a measure of how much they move compared to the overall market (where 1.0 is average), is below 1.0, indicating less risk. But remember, this steadiness often means they lag during roaring bull markets when high-flyers soar.
First up, the stocks to consider offloading—those facing potential turbulence that could erode your portfolio's value.
Sherwin-Williams (SHW)
Rolling One-Year Beta: 0.71
Sherwin-Williams, a titan in the paint and coatings world, crafts everything from home improvement paints to industrial coatings, serving both DIY enthusiasts and professional contractors. It's traded on the NYSE under the ticker SHW.
Why might SHW be a risky bet right now?
Its core operations are showing signs of weakness, with organic revenue growth falling short over the last couple of years. This hints that the company might rely on strategic acquisitions to reignite expansion, rather than organic momentum—a strategy that can be hit-or-miss.
Looking ahead, demand appears sluggish for the next year, with Wall Street analysts forecasting a modest 2.3% growth rate. In a sector like home improvement, this could mean fewer projects and tighter budgets for consumers.
Over the past five years, its free cash flow margin has dipped by 7.6 percentage points, pointing to hefty investments aimed at maintaining its competitive edge. For newcomers, free cash flow margin is the percentage of revenue left after expenses and investments—it's like the breathing room a business has to grow or reward shareholders.
At a share price of $333.31, Sherwin-Williams carries a forward price-to-earnings (P/E) ratio of 27.9x, which compares its stock price to its expected earnings per share. This valuation might seem elevated, suggesting it's priced for perfection. But is it worth the gamble? Delve into our complimentary research report to explore why other opportunities might shine brighter than SHW.
ICU Medical (ICUI)
Rolling One-Year Beta: 0.60
Established in 1984 with a focus on intensive care, ICU Medical specializes in medical devices for infusion therapy, vascular access, and critical care, supplying hospitals and healthcare facilities nationwide. It's listed on NASDAQ as ICUI.
What leads us to believe ICUI could underperform?
Revenue trends have been lackluster over the past two years, with just 1.7% annual growth—well below what's typical for healthcare firms, which often benefit from steady demand for medical supplies.
Projections indicate a sharp 10.6% drop in sales over the coming year, as market demand seems to be fading, possibly due to shifts in healthcare spending or competition.
Despite revenue increases, earnings per share have declined by 19.1% annually over five years, revealing that new sales aren't translating into profits. This could stem from rising costs or pricing pressures, making each dollar of revenue less valuable.
Trading at $113.63 per share, ICU Medical's forward P/E stands at 16.9x, which might look reasonable but could mask underlying challenges. Curious about the full picture? Our free, detailed research report breaks down why ICUI might not meet our standards for long-term holding.
Now, shifting gears to the one stock we're keeping an eye on—a potential beacon in the low-volatility space.
Tractor Supply (TSCO)
Rolling One-Year Beta: 0.62
Originally a mail-order outfit for tractor parts, Tractor Supply has evolved into a go-to retailer for rural essentials, from farming gear and hardware to pet supplies, catering to countryside lifestyles. Find it on NASDAQ under TSCO.
Why are we optimistic about TSCO?
The company's aggressive expansion into new store locations shows a proactive approach to tapping underserved markets, like rural areas hungry for convenient shopping options.
Analysts predict 6.8% revenue growth in the next year, building on a strong six-year track record of momentum that suggests it's riding a wave of consumer demand.
Impressive returns on capital highlight savvy management that's adept at identifying and scaling profitable ventures, turning investments into real value for shareholders.
At $53.72 per share, Tractor Supply's forward P/E is 24.2x, reflecting confidence in its future earnings. Is this the moment to jump in? Our exhaustive research report, available free to active Edge members, provides the insights you need to decide.
But here's where it gets controversial: In a market obsessed with tech giants and flashy disruptors, are we undervaluing the steady performers like Tractor Supply that serve everyday needs? Some investors swear by high-growth stocks for quick riches, while others argue that reliable, low-volatility picks like this one build wealth over time without the heart-stopping swings. What do you think—does stability trump excitement in your portfolio?
And this is the part most people miss: Even in turbulent times, like the market plunge sparked by Trump's proposed 2025 tariffs, resilient stocks can bounce back stronger. After that April shockwave, equities rallied impressively, leaving hasty sellers regretting their moves. To capitalize on such recoveries, consider our curated list of Top 9 Market-Beating Stocks—a selection of high-quality picks that have outperformed the market by 183% over the past five years (as of March 31, 2025). For instance, back in 2020, our list featured now-household names like Nvidia, which skyrocketed 1,545% from March 2020 to March 2025, alongside hidden gems like Kadant, a small-cap firm that delivered a 351% five-year return. Imagine discovering your next big winner—StockStory makes it free and easy to explore these opportunities.
As StockStory expands, we're on the lookout for passionate talent. If you're a trailblazer in markets and AI, from zero to one, check out our open equity analyst and marketing positions.
What are your thoughts on balancing stability and growth in investing? Do you side with the steady-eddy stocks or chase the high-volatility thrills? Share your opinions in the comments—do you agree that low-volatility can sometimes mean missed opportunities, or is it the smart play for risk-averse folks? Let's debate!
